Announce Date | 08/06/2025 |
EPS Normalized Actual | $2.36 (Beat by $0.0099999999999998) |
EPS GAAP Actual | $2.36 (Beat by $0.0099999999999998) |
Revenue Actual | $1.89B |
Revenue Surprise | Beat by $1890M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.02797 |
EPS GAAP Estimate | $1.02797 |
Revenue Estimate | $1.253490725B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 6.65 | 13.13 | 6.02809 | 7.27539 | 2 |
Dec 2028 | 6.49 | 13.46 | 5.88305 | 7.10034 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.3696 | 0.51764 | 1.89B | 16.83% | 293.85M |
FQ1 2025 (Mar 2025) | 1.85 | 1.85 | 1.663B | 11.61% | 1663M |
FQ4 2024 (Dec 2024) | 1.89 | 1.89 | 1.524B | -3.08% | 1524M |
FQ3 2024 (Sep 2024) | 1.55 | 1.55 | 1.37B | 7.08% | 1370M |
FQ2 2024 (Jun 2024) | 2.3 | 2.3 | 1.572B | -12.91% | 1572M |
FQ1 2024 (Mar 2024) | 1.03 | 1.03 | 1.47B | -36.87% | 1470M |
FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 1.571B | 100% | 1571M |
FQ3 2023 (Sep 2023) | 0.85 | 0.85 | 1.273B | -82.33% | 1273M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.02797
Consensus Revenue Estimates
1.253490725B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.5479 | -- | 1.41503 | 1.64502 | 1 |
FQ3 2027 (Sep 2027) | 0.40876 | -- | 0.38102 | 0.43062 | 2 |
FQ2 2027 (Jun 2027) | 1.38192 | -- | 1.28815 | 1.45583 | 2 |
FQ1 2027 (Mar 2027) | 1.88311 | -- | 1.75533 | 1.98383 | 2 |
FQ4 2026 (Oct 2026) | 0.23399 | -- | 0.20438 | 0.26096 | 3 |
FQ3 2026 (Jul 2026) | 1.32539 | -- | 1.15766 | 1.47815 | 4 |
FQ2 2026 (Jun 2026) | 1.25633 | -88.61 | 1.16001 | 1.36541 | 5 |
FQ1 2026 (Mar 2026) | 1.71835 | -7.66 | 1.5866 | 1.86755 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.68B | -- | 1.57B | 1.76B | 2 |
FQ3 2027 (Sep 2027) | 1.29B | -- | 1.22B | 1.34B | 2 |
FQ2 2027 (Jun 2027) | 1.49B | -- | 1.42B | 1.55B | 2 |
FQ1 2027 (Mar 2027) | 1.54B | -- | 1.46B | 1.61B | 2 |
FQ4 2026 (Oct 2026) | 1.18B | -- | 1.06B | 1.28B | 4 |
FQ3 2026 (Jul 2026) | 1.56B | -- | 1.41B | 1.7B | 5 |
FQ2 2026 (Jun 2026) | 1.52B | -24.68 | 1.43B | 1.62B | 5 |
FQ1 2026 (Mar 2026) | 1.48B | -12 | 1.4B | 1.58B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.85196 | 2.3696 | 0.51764 | 21.85% |
FQ1 2025 (Mar 2025) | 1.85 | 1.85 | 100% | |
FQ4 2024 (Dec 2024) | 1.89 | 1.89 | 100% | |
FQ3 2024 (Sep 2024) | 1.55 | 1.55 | 100% | |
FQ2 2024 (Jun 2024) | 2.3 | 2.3 | 100% | |
FQ1 2024 (Mar 2024) | 1.03 | 1.03 | 100% | |
FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 100% | |
FQ3 2023 (Sep 2023) | 0.85 | 0.85 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $1.6B | $1.89B | $293.85M | 15.55% |
FQ1 2025 (Mar 2025) | $0B | $1.66B | $1663M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.52B | $1524M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.37B | $1370M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.57B | $1572M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.47B | $1470M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.57B | $1571M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.27B | $1273M | 100% |